LATEST ALERTS
TobaccoIntelligence takes an overview of recent market developments for PMI’s IQOS heated tobacco system, revealing which countries have the biggest growth, who is likely to use the device and what the future might hold
TobaccoIntelligence considers the effects the possible re-merger of Philip Morris International (PMI) and Altria might have on the combustible and alternatives markets in the US and beyond
In this far-reaching report, we look at the varied legal approaches to tobacco alternative products across Latin America, focusing on Brazil, Mexico, Argentina, Panama, Colombia, Chile and Uruguay
British American Tobacco (BAT) may get two heated-tobacco products onto the US market before IQOS can be launched there, thanks to its decision to take a different route to FDA approval
While sales of traditional cigarettes continue to decline worldwide, PMI is increasingly relying on its heated-tobacco device IQOS to buoy up its financial results, particularly through sales in Japan and Korea
British American Tobacco claims to be the largest reduced-risk product company in the world following its acquisition of Reynolds American and says it will build on this through a variety of HnB, moist tobacco and oral tobacco brands
Agency’s science committee agrees that PMI product decreases exposure to dangerous chemicals, but won’t accept broader claims of long-term risk reduction
ECigIntelligence’s review of the year gone by reflects the big stories of the e-cigarette world in 2017, the trends in regulation, the developing and diverging markets, the science and innovation, and peers into the crystal ball to consider where it all goes from here
Big Tobacco is moving towards a smoke-free future, with all the leading companies indicating a focus in 2018 on next generation products, whether e-cigarettes or heated tobacco products
The US FDA has missed its own 180-day deadline for replying to the premarket tobacco application (PMTA) by Philip Morris International for its IQOS heated tobacco products
The American Vaping Association has written to FDA commissioner Scott Gottlieb urging him to approve PMI’s heated tobacco product iQOS for sale in the US
As PMI’s iQOS comes under consideration by the US FDA, we examine the hurdles it – and other – heated tobacco and e-cigarette products will have to clear to obtain authorisation for commercialisation and reduced-risk claims.
A move by the US FDA to reduce the nicotine content in cigarettes to non-addictive levels could encourage Big Tobacco to put yet more effort into alternatives
2017 has already been a significant year in the short history of e-cigarettes – and there is more to come in the remaining five months of a the year
The $49.4bn takeover of Reynolds American by British American Tobacco (BAT) is set to go through next week after being approved by shareholders of both companies.
New research shines a little light on how Japanese consumers are reacting to iQOS, and how HnB products compare with both combustibles and e-cigarettes on the crucial question of nicotine delivery.
Philip Morris International (PMI) has submitted its iQOS heat-not-burn system for approval by the U.S. Food and Drug Administration (FDA).
U.S. tobacco maker Reynolds American is preparing to test-market a heat-not-burn product which it hopes the regulator will approve as reduced-risk.
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of FREE platform access: Demo our data contents without commitment
"*" indicates required fields
